Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable results in early trials for weight loss . It works by targeting both hormones : GLP-1 and GIP, which https://idayodf640866.blogdemls.com/40599560/this-new-hope-for-size-management